美股A股
StockGist

Lumexa Imaging Holdings, Inc. Common Stock

LMRINASDAQ · Healthcare · Medical - Devices
暂无公司简介
$13.43+1.67%
报价 2026-11-06
市值
$1.29B
EV
$2.2B
PE (TTM)
–
预期 PE (FY2026)
20.9x
52 周区间距高点 0.0%
$9.88$13.43

筛选结果

pipeline · 2026-11-06
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

同行业市值相近 · Medical - Devices
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
LMRILumexa Imaging Holdings, Inc. Common Stock$1.29B+1.7%+4.9%10.9%–19.2x40.5x
CNMDCONMED Corporation$1.53B-2.5%-0.4%56.4%21.3x10.9x11.6x
PRCTPROCEPT BioRobotics Corporation$1.18B+1.7%+21.1%66.3%–––
TNDMTandem Diabetes Care, Inc.$1.18B-6.0%+7.1%56.9%–––
ATECAlphatec Holdings, Inc.$1.15B-4.6%+13.4%71.5%–51.6x234.8xGARP
IRMDIRadimed Corporation$1.1B+0.9%+10.3%76.8%56.2x42.1x65.4x
SIBNSI-BONE, Inc.$1.09B-0.1%+16.2%79.3%–––
IARTIntegra LifeSciences Holdings Corporation$1.04B-5.0%+0.8%51%80.0x12.0x10.6x
CBLLCeriBell, Inc.$1.03B+2.2%+29.3%88.9%–––
同行中位数––+11.8%68.9%56.2x27.0x38.5x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
Revenue$264.2M$252.5M$267.7M$258.9M$251.4M$245M$248M
Gross Margin10.9%9.8%11.1%15.3%15.6%14.9%8.7%
Operating Margin1.7%1.8%-2.8%5%4.4%4.1%6.1%
Net Income$2.7M$1.7M$-28.7M$-3.5M$-7.2M$-7.7M$-25.1M
Diluted EPS0.030.02-0.38-0.04-0.08-0.08-0.26
Operating Cash Flow$32.8M$2.9M$17.1M$11.9M$2.1M$-14M$25.3M

研究材料